Indivior PLC (LON:INDV – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 811.18 ($10.44) and traded as low as GBX 733.50 ($9.44). Indivior shares last traded at GBX 746 ($9.60), with a volume of 9,229,962 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($23.17) price target on shares of Indivior in a research note on Tuesday, December 17th.
Check Out Our Latest Stock Analysis on Indivior
Indivior Stock Up 0.2 %
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
- Five stocks we like better than Indivior
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Start Investing in Real Estate
- Qualcomm Stock Is Coiling for a Breakout
- What is the Dow Jones Industrial Average (DJIA)?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.